Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO)

Centre Hospitalier Intercommunal Creteil

Status: Withdrawn

Conditions: COVID19

Treatments: Diagnostic Test: Sars-Cov2 serology; Diagnostic Test: RT-PCR SARS-Cov2

Study type: Observational

Funder types: Other

Identifiers

NCT04416893

COVILLE2

Details and patient eligibility

About

France and in particular the paris area was one of the countries most affected by the pandemic Covid19.

School closures and a generalized lockdown of the population were instituted in France from 17 March 2020 to 10 May 2020. Schools and nurseries have reopened partially since 11 May 2020. From 2 June, this reopening is more widespread. By combining the search for SARS-Cov2 viruses by PCR and micro-method serology we will be able to evaluate both the infection at a given time and also older contact with SARS-CoV2.

The temporal knowledge of the prevalence of SARS-Cov2 carriage and the serological status (IgM and IgG) after return to the community are crucial information to evaluate the speed of spread of the virus in children. This is the objective of COVILLE2, phase 2 of the COVILLE study.

Sex: All

Ages: Under 15 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Birth to 15 years old
• taking over the community (kindergarten, school, college, holiday centre, etc.) for at least 1 week

Exclusion criteria

• refusal to participate

Trial design

0 participants in 1 patient group

Children under 15 years of age in a community

Description:

Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc.

Treatment:

Diagnostic Test: Sars-Cov2 serology

Diagnostic Test: RT-PCR SARS-Cov2